Search clinical trials for: Radio opaque contrast

Total 19124 results

University of Sydney
Austin Health; Peter MacCallum Cancer Centre, Australia; Western Sydney Local... and other collaborators

Recruiting

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy (ROCK-RT)

Liver Neoplasm

Australia
Philippe Gauthier

Completed

Pericapsular Nerve Group Block: An Imaging Study for Determination of the Spread of the Injectate Using 3-D CT Scan

Post Operative Pain | Mechanisms of Analgesia

Belgium
Nanjing Medical University

Unknown

Contrast Induced Acute Kidney in Patients With Acute Stroke

Stroke, Acute

China
Massachusetts General Hospital

Recruiting

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Liver Cirrhosis | Portal Hypertension | Hepatic Cell Carcinoma

United States
Massachusetts General Hospital
Takeda Development Center Americas, Inc.

Recruiting

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

Crohn Disease

United States
Massachusetts General Hospital

Not yet recruiting

PET/MRI of Primary Sclerosing Cholangitis

PSC

United States
Uppsala University

Not yet recruiting

Incidence of Acute Kidney Injury After Administration of Iodine Contrast Media in Patients With Reduced Renal Function (COINCIDES)

Acute Kidney Injury Following Administration of Contrast Media

Sweden
Case Comprehensive Cancer Center
The Cleveland Clinic

Not yet recruiting

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Brain Tumor | Brain Metastases | Brain Necrosis

United States
AB-CT - Advanced Breast-CT GmbH
CRO Dr. med. Kottmann GmbH; RQM+ (Germany) GmbH

Recruiting

Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics

Breast Cancer Diagnosis

Netherlands, Germany
Jung Im Jung
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Chest CT Using Low-concentration Iodine Contrast Media

Pulmonary Disease

Korea, Republic of
OHSU Knight Cancer Institute
Oregon Health and Science University

Recruiting

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Glioma

United States
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)

Contrast Enhancement in Magnetic Resonance Imaging | Non-central Nervous System Pathology

United States, Sweden, Japan, Czechia, China, Hungary, Poland, Italy, United Kingdom, Turkey, Korea, Republic of, Germany, Taiwan, France, Argentina, Bulgaria, Canada
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)

Contrast Enhancement in Magnetic Resonance Imaging | Central Nervous System Pathology

France, Turkey, Czechia, China, Japan, Korea, Republic of, United Kingdom, Italy, United States, Hungary, Argentina, Bulgaria, Canada, Germany, Sweden
Bayer

Recruiting

A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)

Children | Contrast Enhancement in Magnetic Resonance Imaging

United States, Japan, China, Canada, Czechia, Poland, Argentina, Bulgaria, Belgium, Germany, Sweden, Hungary, Italy
Asan Medical Center

Not yet recruiting

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Brain Metastases | Radiosurgery

Korea, Republic of
Menoufia University

Not yet recruiting

Preoperative Prediction of Flexible Ureteroscopy Outcome in the Treatment of Renal Calculi

Flexible Ureteroscopy
Peking University People's Hospital

Not yet recruiting

Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis (RECUR)

Pancreatitis, Chronic
Peking Union Medical College Hospital

Recruiting

Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

Pancreatic Cancer | Ultrasonography | First-line Chemotherapy

China
Rigshospitalet, Denmark
Hvidovre University Hospital; Bispebjerg Hospital; The Danish Rheumatism Association and other collaborators

Recruiting

US and MRI of the Forefoot: Intermetatarsal Bursitis or Morton's Neuroma

Morton Neuroma | Intermetatarsal Neuroma | Intermetatarsal Bursitis

Denmark
American College of Radiology
GE Healthcare; Breast Cancer Research Foundation

Recruiting

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts (CMIST)

Breast Cancer

United States
Thomas Jefferson University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Liver Diseases | Portal Hypertension

United States, Switzerland
Indiana University
Children's Hospital of Philadelphia

Recruiting

Registering Genomics and Imaging of Tumors (ReGIT) (ReGIT)

Glioma

United States
Thomas Jefferson University

Recruiting

Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

Intrahepatic Cholangiocarcinoma

United States
University of Wisconsin, Madison
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Recruiting

Fully Automated High-Throughput Quantitative MRI of the Liver

Healthy | Iron Overload | Liver Fat

United States
Leiden University Medical Center
Erasmus Medical Center

Recruiting

Vascular Signature Mapping of Brain Tumor Genotypes (VASIM)

Glioma

Netherlands
Ping Liang

Recruiting

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Hepatocellular Carcinoma | Surgery | Ablation | Prognosis | Contrast-enhanced Ultrasound

China
Institut Cancerologie de l'Ouest
PHRC-I

Recruiting

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy (CATAREV-B)

Catheter Dysfunction

France
Korea University Guro Hospital

Recruiting

SLN Detection With Tc-MSA-ICG in Lung Cancer Patients

Lung Cancer

Korea, Republic of
Guiyang Medical University

Not yet recruiting

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Head and Neck Squamous Carcinoma

China
National Cancer Institute (NCI)

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Sporadic Papillary Renal Cell Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

Breast Carcinoma

United States
University of Wisconsin, Madison
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

Cirrhosis, Liver | Gastroesophageal Varices

United States
Kinepict Health Ltd.
Semmelweis University; Bács-Kiskun County Teaching Hospital

Recruiting

Digital Variance Angiography for Contrast Media Dose Reduction in Carotid Artery Stenting

Carotid Artery Diseases

Hungary
Mayo Clinic
National Cancer Institute (NCI); United States Department of Defense

Recruiting

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

Hepatocellular Carcinoma

United States
Ping Liang

Recruiting

Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging

Focal Liver Lesions | Contrast-enhanced Ultrasound

China
Instituto do Cancer do Estado de São Paulo

Recruiting

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Medullary Thyroid Cancer | Lymph Node Metastases | Thyroid Neoplasia | Well-Differentiated Thyroid Cancer

Brazil
Stanford University
NovoCure Ltd.

Recruiting

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma | Newly Diagnosed Glioblastoma

United States
Guerbet
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY)

Cognitive Function | Motor Function | Contrast Media

United States, Korea, Republic of, Italy, Brazil, Canada, Russian Federation
Duke University

Recruiting

Quantitative MRI for Functional Assessment Following SBRT for Spinal Metastases

Spinal Metastases

United States
Columbia University

Recruiting

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Abdominal Cancer | Pelvic Cancer

United States
Helsinki University Central Hospital

Recruiting

Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function (INCARO)

Acute Abdomen | Radiocontrast Nephropathy

Finland
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), The ARCHON-1 Trial

Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell Carcinoma

United States
Medical University of Graz
Amt der Steiermärkischen Landesregierung, Abteilung 3

Recruiting

Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols (CMR-TECH)

Healthy

Austria
Organon and Co

Active, not recruiting

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

Contraception

United States, Puerto Rico
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Gliosarcoma | MGMT-Unmethylated Glioblastoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
National Institutes of Health Clinical Center (CC)

Completed

LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation

Liver Neoplasms | Liver Cancer | Hepatocellular Cancer | Hepatic Cancer

United States
Massachusetts General Hospital

Withdrawn

PET/MRI in Endometrial Cancer

Endometrial Mixed Cell Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Cytoreductive Surgery | High Grade Serous Carcinoma | Grade 3 Endometrial Endometrioid Adenocarcinoma

United States
Thomas Jefferson University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Hepatocellular Carcinoma

United States
European Institute of Oncology

Active, not recruiting

Contrast-Enhanced Spectral Mammography (CESM) (CESM)

Breast Cancer

Italy

Search clinical trials for: Radio opaque contrast

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations